Ultragenyx Pharmaceutical
RARE
RARE
126 hedge funds and large institutions have $1.96B invested in Ultragenyx Pharmaceutical in 2015 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 54 increasing their positions, 25 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
26% more funds holding
Funds holding: 100 → 126 (+26)
Holders
126
Holding in Top 10
1
Calls
$3.73M
Puts
$2.83M
Top Buyers
| 1 | +$56.8M | |
| 2 | +$41.9M | |
| 3 | +$34.2M | |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$22.8M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$20.7M |
Top Sellers
| 1 | -$32.1M | |
| 2 | -$31M | |
| 3 | -$13.5M | |
| 4 |
CI
Cowen Inc
New York
|
-$9.01M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$7.25M |